Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma

European Journal of Haematology

Volumn 68, Issue 2, 2002, Pages 117-119

  Cohen, Yossi ^a   Amir, Gail ^a   Polliack, Aaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anti CD2O antibodies; Immunosuppression; Rapid dissemination; Secondary malignancy

Indexed keywords

FLUDARABINE; RITUXIMAB;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNE DEFICIENCY; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, MERKEL CELL; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RECURRENCE; SALVAGE THERAPY; VIDARABINE;

EID: 0036246055     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01600.x     Document Type: Article

References (21)

1. Infectious and immunosuppressive complications of purine analog therapy
2. Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur
3. Fludarabine therapy may precipitate large cell transformation in chronic lymphocytic leukemia but not in follicular lymphoma
4. Fludarabine (FMP) and the risk of occurance of Richter's syndrome among B-CLL
5. Large cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: Natural history or possible therapy related complication?
6. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-96: A search for common mechanisms
7. Transformation to Richter's syndrome or prolymphocytic leukemia (PLL), and other second hematologic malignancies in patients with chronic lymphocytic leukemia (CLL): An intergroup study (CALGB 9011)
8. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphocytic leukemias
9. Merkel-cell carcinoma in a renal transplant patient
10. Merkel-cell carcinoma in a renal transplant patient: Increased incidence?
11. Merkel-cell carcinoma developing after bone marrow transplantation
12. Merkel-cell carcinoma in a stem cell transplant patient
13. Rapid growth of cutaneous neuroendocrine (Merkel-cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody
14. Merkel cell carcinoma arising after therapeutic immunosuppression
15. Merkel-cell carcinoma in the setting of HIV infection
16. Merkel-cell tumor in an HIV-positive patient
17. Fine-needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients: A report of two cases and review of the literature
18. Primary nodal neuroendocrine (Merkel-cell) tumor in a patient with HIV infection
19. Lymph node Merkel-cell carcinoma with no evidence of cutaneous tumor - Report of two cases
20. Cutaneous lymphoma-simulating Merkel-cell carcinoma: Molecular genetic demonstration of a clonal disease with divergent immunophenotypes
21. Merkel-cell carcinoma can be distinguished from metastatic small-cell carcinoma using antibodies to cytokeratin-20 and thyroid transcription factor 1